PEMFLEXI

Serial Number 87249346
606

Registration Progress

Application Filed
Nov 28, 2016
Under Examination
Jun 13, 2017
Approved for Publication
Apr 18, 2017
Published for Opposition
Apr 18, 2017
Registered

Basic Information

Serial Number
87249346
Filing Date
November 28, 2016
Published for Opposition
April 18, 2017
Abandonment Date
July 16, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 16, 2018
Classes
005

Rights Holder

Eagle Pharmaceuticals Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Legal Representation

Attorney
Jacqueline M. Lesser

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description
Jul 16, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 16, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 7, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 5, 2017 EXT1 S SOU EXTENSION 1 FILED
Dec 5, 2017 EX1G S SOU EXTENSION 1 GRANTED
Jun 13, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 18, 2017 PUBO A PUBLISHED FOR OPPOSITION
Apr 18, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2017 DOCK D ASSIGNED TO EXAMINER
Dec 2, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of lung cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005